Federation of Asian Biotechnology Association (FABA) is organizing an International Conference on Stem Cell and Regenerative Medicine-2012 from March 22 to 24 at Indian School of Business (ISB) in Hyderabad.

The big event at ISB is expected to be inaugurated by Dr A P J Abdul Kalam, former president of India. The gathering at the event is also expected to be addressed by Dr Stephen Minger, a pioneer of the Stem Cell technology. Dr Geeta Reddy, Minister for Major Industries, Sugar, Commerce & Export Promotion, from Government of AP is also expected at the event.

Marking the event, FABA and YES Bank Ltd will release a white paper on ‘Stem Cell: Transforming Global Medicine and Healthcare Industry’ on the occasion.

World renowned experts are set to participate in the conference where it is expected to feature over 40 renowned international speakers, including Dr Lukas Utigar of Lonza Bioscience, Prof. Mahendra S Rao of Centre for Regenerative Medicine, NIH, USA, and Dr Mohan Vemuri of Life Technologies, USA.

In India the stem cell industry is still at a very nascent stage. The next three years will be very crucial for the Industry as the National Apex Committee for Stem Cell Research and Therapy (NAC-SCRT) has now been set up to formulate a set of rules. In the coming few years, the new regulations are expected to fuel innovation, research and commercialization of the stem cell industry in the country.

The Stemcell 2012 will showcase the status of trials in stem cell therapies, latest research, regulatory laws, cutting-edge technologies and business opportunities in the industry with a clear focus on therapeutics. The participants include doctors, researchers, entrepreneurs from the fields of Medicine and Biotechnology, investors, government officials and members of various fraternities from different countries. A key activity is the ‘one-on-one ‘business meetings that would accelerate transparences for commercialization and industry growth with specific opportunities for networking, funding and forging new alliances.

The conference is definitely an apt platform for sharing perspectives and ideas on research, and various challenges in the industry with commercial applications. The event is also expected to provide an opportunity to forge mutually beneficial relationships. It will also help Overseas and Indian Companies to form Global tie-ups with their counterparts across the world.

“From an international viewpoint, the event will be a gateway of information and ingress point to Indian Stem Cell Business world and vice versa,” said Dr B S Bajaj, convener and secretary general, FABA.